COVID-19 resources | Our faculty and staff are committed to providing you an exceptional learning experience this September.

CSS Research Grants for Uterine Cancer

The Canadian Cancer Society (CCS) is issuing a special call for grant applications focused on rare and aggressive uterine cancers, with an emphasis on uterine carcinosarcoma in particular. As a result of a generous donation, there is funding available to support one meritorious application that will impact our understanding of uterine carcinosarcoma and other aggressive uterine cancers, particularly as it relates to the prevention, early detection, diagnosis, and/or treatment of these hard-to-treat cancers.

Eligible types of uterine cancer include:

  • Uterine carcinosarcoma
  • Serous carcinoma
  • Uterine leiomyosarcoma
  • Uterine clear cell carcinoma
  • Endometrial stromal sarcoma (high-grade)
  • Undifferentiated sarcomas

The funding envelope will support a budget of up to $180,000 over 2 years (maximum of $90,000 per year). This grant is renewable for an additional 2 years of funding pending review.

Full applications due: April 6, 2020
Anticipated start date: June 1, 2020

All applications must be submitted through the online application system (EGrAMS) by 5p.m. EST on the deadline date. Submissions will not be accepted beyond these times.

Agency Name: 
Canadian Cancer Society
Contact Name: 
Penny D'Agnone
Grant Amount: 
Up to $180,000 over two years, renewable upon review
Grant Location: 
External Deadline: 
Tuesday, April 14, 2020
Internal Deadline: 
Tuesday, April 7, 2020
Grant Type: 
Grant Area: 
Natural Science
Grant Eligibility: